Baclosign: Targeted Muscle Spasticity Relief with Baclofen
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.96 | $57.50 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $86.26 $71.63 (17%) | 🛒 Add to cart |
| 120 | $0.73 | $115.01 $87.77 (24%) | 🛒 Add to cart |
| 180 | $0.69 | $172.51 $124.09 (28%) | 🛒 Add to cart |
| 270 | $0.67 | $258.77 $179.58 (31%) | 🛒 Add to cart |
| 360 | $0.62
Best per pill | $345.03 $224.97 (35%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.54 | $45.40 (0%) | 🛒 Add to cart |
| 20 | $3.98 | $90.80 $79.70 (12%) | 🛒 Add to cart |
| 30 | $3.19 | $136.19 $95.84 (30%) | 🛒 Add to cart |
| 60 | $3.04 | $272.39 $182.60 (33%) | 🛒 Add to cart |
| 90 | $2.87 | $408.58 $258.27 (37%) | 🛒 Add to cart |
| 120 | $2.72 | $544.78 $325.86 (40%) | 🛒 Add to cart |
| 180 | $2.51 | $817.17 $450.96 (45%) | 🛒 Add to cart |
| 270 | $2.35 | $1225.75 $634.57 (48%) | 🛒 Add to cart |
| 360 | $2.25
Best per pill | $1634.34 $810.11 (50%) | 🛒 Add to cart |
Baclosign is a prescription muscle relaxant containing the active ingredient baclofen, designed specifically for the management of muscle spasticity associated with conditions such as multiple sclerosis, spinal cord injuries, and other neurological disorders. By acting on the central nervous system, it reduces the frequency and severity of muscle spasms, thereby improving mobility, decreasing discomfort, and enhancing overall functional capacity. This medication is intended for patients under strict medical supervision to ensure optimal therapeutic outcomes while minimizing risks.
Features
- Active ingredient: Baclofen 10mg or 20mg tablets
- Mechanism: GABA-B receptor agonist, suppressing reflex activity at the spinal level
- Formulation: Oral tablets with scored design for accurate dosing
- Bioavailability: Rapidly absorbed, peak plasma concentration within 2–3 hours
- Half-life: Approximately 3–4 hours, requiring multiple daily doses for sustained effect
- Excretion: Primarily renal, requiring dose adjustment in impaired renal function
Benefits
- Reduces muscle spasticity and associated pain, improving comfort and rest
- Enhances range of motion and voluntary motor control for daily activities
- May decrease the frequency of spasms, leading to improved sleep quality
- Supports rehabilitation efforts by allowing better participation in physical therapy
- Can reduce complications related to severe spasticity, such as contractures
- Offers a well-established safety profile when used as directed under medical supervision
Common use
Baclosign is commonly prescribed for the symptomatic treatment of spasticity resulting from multiple sclerosis, spinal cord lesions, or other neurological diseases. It is also used off-label in certain cases of intractable hiccups, trigeminal neuralgia, and alcohol withdrawal support, though these uses require careful clinical evaluation. The medication is typically part of a comprehensive management plan that may include physical therapy and other supportive treatments.
Dosage and direction
Dosage must be individualized based on patient response and tolerance. The typical starting dose for adults is 5mg administered three times daily. This may be increased by 5mg per dose every three days until the desired effect is achieved. The maximum recommended daily dose is 80mg (20mg four times daily). Tablets should be taken with water, with or without food, though consistent administration relative to meals is advised. Abrupt discontinuation must be avoided; taper gradually under medical supervision.
Precautions
Patients should be monitored for sedation, dizziness, or confusion, especially during dose titration. Use with caution in individuals with a history of seizure disorders, psychiatric conditions, or autonomic dysreflexia. Renal impairment necessitates dose adjustment. Baclosign may impair alertness; patients should avoid driving or operating machinery until their response is known. Elderly patients may be more sensitive to effects and require lower dosing.
Contraindications
Baclosign is contraindicated in patients with hypersensitivity to baclofen or any component of the formulation. It should not be used in those with significant renal impairment unless benefits clearly outweigh risks. Avoid use in combination with other central nervous system depressants where additive effects could be dangerous. Not recommended during pregnancy unless absolutely necessary and under specialist supervision.
Possible side effects
Common side effects include drowsiness, dizziness, weakness, fatigue, nausea, and headache. Less frequently, patients may experience confusion, hypotension, insomnia, or constipation. Rare but serious adverse effects can include hallucinations, seizures, respiratory depression, or severe allergic reactions. Any unusual symptoms should be reported to a healthcare provider immediately.
Drug interaction
Baclosign may interact with alcohol, opioids, benzodiazepines, antidepressants, and other CNS depressants, potentially enhancing sedative effects. Concomitant use with antihypertensives may increase the risk of hypotension. Monoamine oxidase inhibitors (MAOIs) and baclofen may interact to increase CNS toxicity. Always inform your prescriber of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to catch up. Maintaining a consistent dosing schedule is important to stabilize therapeutic effects.
Overdose
Symptoms of overdose may include vomiting, hypotonia, respiratory depression, coma, or seizures. Management is supportive and may include airway protection, activated charcoal if ingestion was recent, and symptomatic treatment. There is no specific antidote. Contact emergency services or a poison control center immediately if overdose is suspected.
Storage
Store at room temperature (15–30°C) in a tightly closed container, away from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized dosage recommendations. Do not initiate, adjust, or discontinue Baclosign without medical supervision.
Reviews
Clinical studies and patient reports consistently note Baclosign’s efficacy in reducing spasticity and improving quality of life. Many users report significant functional improvement, though some mention initial drowsiness that often diminishes with continued use. Always discuss personal experiences and side effects with your prescribing physician to tailor therapy appropriately.